Best of EAS 2025 Agenda
Exploring the Future of Atherosclerosis Research
The Best of EAS 2025 features a carefully curated agenda designed to showcase the latest advancements in atherosclerosis research and cardiovascular health. Attendees will engage in expert-led discussions, interactive workshops, and groundbreaking presentations. The tentative agenda is given below.
| Time | Agenda | Speakers |
|---|---|---|
| 9.00–9.10 am | An introduction from Inside Health Communications | Dr. Aridita Datta Mukherjee |
| 9.10–9.25 am | OLive Lecture: Opening Ceremony and welcome address Introduction to EAS: highlight EAS activities - Outreach & Young Fellows |
Prof. Kausik Ray (Immediate Past President, EAS) |
| Live Lecture "The Impact and Value of the EAS: How it has shaped my scientific journey" | Dr. Jeffrey Kroon (EAS 2025) | |
| 9.25–9.45 am | Live key note lecture: "Unmet Needs and challenges in Primary Prevention of Atherosclerosis: An Asian Perspective" | Speaker: Dr. David Foo (Immediate Past President, SCS) |
| 9.45–11.05 am | Non-traditional risk factor for atherosclerosis VR1-Environmental pollution: a modifiable risk factor? (Thomas Münzel) VR2- Per particle importance of remnants vs. Lp(a) vs. LDL on cardiovascular disease risk (Elias Björnson) |
Panelist: Dr. Jeffrey Kroon, Dr. Ching Hui Sia, Dr. Colin Yeo (President, SCS) |
| 11.05–11.20 am | Tea break & Networking | |
| 11.20 am – 1.10 pm | Sex and gender in cardiovascular disease VR1- Gender medicine: Effects of sex and gender on cardiovascular disease manifestation and outcomes (Vera Regitz-Zagrosek) VR2- Deciphering the code: Exploring the influence of biological sex and cardiometabolic disease development (Karen Reue) VR3- Acute Coronary Syndromes in the absence of standard modifiable risk factors (SMURFs): Is sex the missing link? (Gemma Figtree) |
Panelist: Prof. Jeanine Roeters van Lennep, Dr. Ting Ting Low, Dr. Joshua Loh, Dr. Sim Hui Wen |
| 1.10–1.55 pm | Lunch | |
| 1.55–3.00 pm | Assessing the vulnerable patient using non-invasive imaging VR1- Advanced coronary CT in risk stratification (Edward Nicol) VR2- The role of imaging in finding the high-risk patient (Jonathan Weir-McCall) | Panelist: Prof. Kausik Ray, Dr. Calvin Chin |
| 3.00–3.30 pm | Tea Symposium - sponsored by Amgen Roadmap to improved CV outcomes: Multidisciplinary strategies for managing hyperlipidaemia in ASCVD Managing ASCVD patients with residual risk: Applying evidence of PCSK9i (from clinical studies) to practice Roadmap to improved outcomes: The clinical challenges in optimizing LDL-C Panel Discussion and Q&A | Speakers: Dr. Koh Choong Hou A/Prof. Doreen Tan |
| 3.30–4.35 pm | Identifying Novel Therapeutic Approaches in Atherosclerosis VR 1- The role of innate immune reprogramming in the pathophysiology of atherosclerosis – a targetable approach? (Niels Riksen) R2- Lp(a) the new target (Sam Tsimikas) | Panelist: Dr. Jeffrey Kroon, Dr. Wann Jia Loh, Dr. William Kristanto A/Prof. Doreen Tan |
| 4.35–4.45 pm | Closing | Prof. Kausik Ray |
| 4.45–6.30 pm | Break | |
| 6.30–7.30 pm | Dinner Symposium- Sponsored by Novartis Title: From Awareness to Action: Overcoming Barriers in Testing and Managing Lipoprotein(a) |
Chair: Dr. Wann Jia Loh Speaker: Prof. Gerald Watts |
* EAS- European Atherosclerosis Society
* SCS- Singapore Cardiac Society
* VR- Video Recording